×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NASDAQ:LHDX

Lucira Health Earnings Date, Estimates & Call Transcripts (2022)

$1.86
0.00 (0.00%)
(As of 07/1/2022 05:43 PM ET)
Add
Compare
Today's Range
$1.81
$1.92
50-Day Range
$1.44
$3.11
52-Week Range
$1.36
$11.10
Volume
38,480 shs
Average Volume
115,551 shs
Market Capitalization
$74.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Earnings Summary

Upcoming
Earnings Date
Aug. 11Estimated
Actual EPS
(May. 12)
$0.35 Beat By $0.43
Consensus EPS
(May. 12)
-$0.08
Last Year's Q2 EPS
(5/13/2021)
-$0.54
Skip Charts & View Estimated and Actual Earnings Data

LHDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LHDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lucira Health Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20221($0.31)($0.31)($0.31) 
Q2 20221($0.34)($0.34)($0.34) 
Q3 20221($0.35)($0.35)($0.35) 
Q4 20221($0.30)($0.30)($0.30) 
FY 20224($1.30)($1.30)($1.30) 
Q1 20231($0.24)($0.24)($0.24) 
Q2 20231($0.68)($0.68)($0.68) 
Q3 20231($0.73)($0.73)($0.73) 
Q4 20231($0.50)($0.50)($0.50) 
FY 20234($2.15)($2.15) ($2.15)

LHDX Earnings Date and Information

Lucira Health last posted its earnings data on May 12th, 2022. The reported $0.35 earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.43. The business had revenue of $90.47 million for the quarter, compared to analyst estimates of $91.78 million. Lucira Health has generated ($1.02) earnings per share over the last year (($1.02) diluted earnings per share). Earnings for Lucira Health are expected to decrease in the coming year, from $0.29 to ($0.52) per share. Lucira Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Lucira Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Estimated)
        
5/12/2022Q1 2022($0.08)$0.35+$0.43$0.39$91.78 million$90.47 million    
3/10/2022Q4 2021($0.55)($0.03)+$0.52$0.14$58.80 million$61.12 million    
11/11/20219/30/2021($0.51)($0.47)+$0.04($0.23)$18.00 million$14.98 million    
8/12/2021Q2 2021($0.34)($0.40)($0.06)($0.38)$6.95 million$12.44 million
5/13/20213/31/2021($0.34)($0.54)($0.20)($0.50)$4.30 million$4.52 million  












Lucira Health Earnings - Frequently Asked Questions

When is Lucira Health's earnings date?

Lucira Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on LHDX's earnings history.

Did Lucira Health beat their earnings estimates last quarter?

In the previous quarter, Lucira Health (NASDAQ:LHDX) reported $0.35 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.43. Learn more on analysts' earnings estimate vs. LHDX's actual earnings.

How can I listen to Lucira Health's earnings conference call?

The conference call for Lucira Health's latest earnings report can be listened to online. Listen to Conference Call

How can I read Lucira Health's conference call transcript?

The conference call transcript for Lucira Health's latest earnings report can be read online. Read Transcript

How much revenue does Lucira Health generate each year?

Lucira Health (NASDAQ:LHDX) has a recorded annual revenue of $93.06 million.

How much profit does Lucira Health generate each year?

Lucira Health (NASDAQ:LHDX) has a recorded net income of -$64.83 million. LHDX has generated -$1.02 earnings per share over the last four quarters.

What is Lucira Health's price-to-earnings ratio?

Lucira Health (NASDAQ:LHDX) has a forward price-to-earnings ratio of 6.41. The price/earnings-to-growth ratio is 0.15.

What is Lucira Health's EPS forecast for next year?

Lucira Health's earnings are expected to decrease from $0.29 per share to ($0.52) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:LHDX) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.